TRADING QUOTES 3:39 AM April 26, 2024
[stock-market-overview stockExchange="NYSENasdaq" width="600px" title="Viveon Health Acquisition Corp. *" equities="VHAQ.U;VHAQ;VHAQ.WS;VHAQ.R" allowSort="true" includeChart="true" logoMaxHeight="20px" logoMaxWidth="90px" height="100%" culture="English-US"]
IPO Terms Details
Business Combination
Related Articles
SEC Filings
SPAC Name : Viveon Health Acquisition Corp. *
| Total Public Proceeds at IPO($mm): | 201.3 |
| %Held in Trust: | 101.0 |
| $Held in Trust per Unit: | $ 10.10 |
| Mgmt's Sector Expertise/Focus: | Healthcare |
| IPO Date: | 2020-12-23 |
| Months to Complete: | 15 |
| Deadline Date: | 2024-04-30 |
| Unit Structure (VHAQ.U) | |
| Share (VHAQ): | 1 Share of Common Stock |
| Warrant (VHAQ.WS) | 1 for 1/2 Warrant |
| Right(VHAQ.R) | 1 for 1/20 |
| Public Warrant Terms: | |
| Exercise Price: | 11.500000000 |
| Redemption Price: | Cash/Cashless: $16.50 |
| Redemption: Cash, Cashless or for Shares | Mgmt's Discretion |
| Underwriters: | |
| Book-runner(s): | Chardan |
| Co-Manager(s): | |
| Fees (Upfront/Deferred): | 2%/3.5% |
| Lawyers: | |
| Issuer's Counsel: | Loeb & Loeb LLP |
| Underwriter's Counsel: | White and Williams LLP |
| Additional Terms: | Crescent term: $9.50, Limitation on redemption rights: 20% |
SPAC Name: Viveon Health Acquisition Corp. *
| CURRENT FUNDS in TRUST: | $7,608,970* |
| EST. PRO RATA AMOUNT IN TRUST: | $11.72* |
| IMPLIED ENTERPRISE VALUE: | $370 million |
| RECORD DATE: | TBD |
| SHAREHOLDER VOTE DATE: | TBD |
| SPAC NameSource: SEC.gov filings and SPAC Insider estimates | |
|---|---|
TRADING QUOTES Business CombinationIPO Terms Details SPAC name: %spacname% CURRENT FUNDS in TRUST: $%ending_trust_ball%* EST. PRO RATA AMOUNT IN TRUST: $%implied_cash_per_share%* IMPLIED ENTERPRISE VALUE: %impliedenterprisevalue% RECORD DATE: %businesscombinationrecorddate% SHAREHOLDER VOTE DATE: %businesscombinationshareholdervotedate% Source: SEC.gov filings and SPAC Insider estimates SPAC name: %spacname% Total Public Proceeds at IPO ($mm): %total% % Held in Trust:
Read More